VVOS · Vivos Therapeutics, Inc.
$0.30
-0.04 (-11.94%)
At close · Aug 17
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.91M
Shares
20.12M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-13 | 65,611 | 429,717 | 495,328 | 60.2% |
| 2026-07-06 | 39,506 | 325,078 | 364,584 | 56.7% |
| 2026-06-29 | 244,933 | 8,517,056 | 8,761,989 | 61.2% |
| 2026-06-22 | 127,875 | 1,358,323 | 1,486,198 | 64.7% |
| 2026-06-15 | 132,797 | 1,026,435 | 1,159,232 | 60.9% |
| 2026-06-08 | 512,030 | 3,540,096 | 4,052,126 | 60.2% |
| 2026-06-01 | 2,013,000 | 44,824,431 | 46,837,431 | 66.3% |
| 2026-05-25 | 27,262 | 249,727 | 276,989 | 53.7% |
| 2026-05-18 | 34,770 | 598,895 | 633,665 | 67.3% |
| 2026-05-11 | 47,079 | 331,668 | 378,747 | 55.7% |
| 2026-05-04 | 42,206 | 537,722 | 579,928 | 61.3% |
| 2026-04-27 | 64,424 | 581,466 | 645,890 | 70.5% |
| 2026-04-20 | 79,498 | 763,997 | 843,495 | 57.8% |
| 2026-04-13 | 63,949 | 1,408,326 | 1,472,275 | 65.5% |
| 2026-04-06 | 103,131 | 1,605,753 | 1,708,884 | 47.2% |
| 2026-03-30 | 8,343 | 261,433 | 269,776 | 63.5% |
| 2026-03-23 | 23,752 | 334,941 | 358,693 | 56.9% |
| 2026-03-16 | 23,376 | 361,740 | 385,116 | 59.0% |
| 2026-03-09 | 23,376 | 455,887 | 479,263 | 60.1% |
| 2026-03-02 | 17,106 | 171,875 | 188,981 | 55.3% |
| 2026-02-23 | 18,489 | 311,167 | 329,656 | 62.5% |
| 2026-02-16 | 18,831 | 56,577 | 75,408 | 37.1% |
| 2026-02-09 | 36,640 | 351,408 | 388,048 | 58.7% |
| 2026-02-02 | 32,036 | 340,739 | 372,775 | 57.2% |
| 2026-01-26 | 38,711 | 381,374 | 420,085 | 69.6% |
| 2026-01-19 | 33,025 | 391,080 | 424,105 | 58.0% |
| 2026-01-12 | 28,355 | 354,840 | 383,195 | 56.1% |
| 2026-01-05 | 39,141 | 372,807 | 411,948 | 60.3% |
| 2025-12-29 | 25,150 | 389,120 | 414,270 | 60.2% |
| 2025-12-22 | 24,843 | 140,475 | 165,318 | 59.2% |
| 2025-12-15 | 52,550 | 361,114 | 413,664 | 56.0% |
| 2025-12-08 | 94,868 | 342,768 | 437,636 | 63.7% |
| 2025-12-01 | 27,133 | 314,778 | 341,911 | 60.1% |
| 2025-11-24 | 55,181 | 354,522 | 409,703 | 69.7% |
| 2025-11-17 | 35,411 | 302,920 | 338,331 | 60.5% |
| 2025-11-10 | 30,689 | 227,391 | 258,080 | 68.4% |
| 2025-11-03 | 29,576 | 443,821 | 473,397 | 60.5% |
| 2025-10-27 | 54,156 | 381,145 | 435,301 | 52.5% |
| 2025-10-20 | 66,760 | 684,569 | 751,329 | 60.7% |
| 2025-10-13 | 145,403 | 1,250,173 | 1,395,576 | 71.6% |
| 2025-10-06 | 343,875 | 481,460 | 825,335 | 63.7% |
| 2025-09-29 | 197,634 | 645,078 | 842,712 | 53.7% |
| 2025-09-22 | 91,153 | 454,432 | 545,585 | 60.9% |
| 2025-09-15 | 165,977 | 2,757,967 | 2,923,944 | 45.7% |
| 2025-09-08 | 37,690 | 239,747 | 277,437 | 50.9% |
| 2025-09-01 | 19,607 | 189,939 | 209,546 | 61.6% |
| 2025-08-25 | 64,386 | 368,753 | 433,139 | 60.6% |
| 2025-08-18 | 56,824 | 467,124 | 523,948 | 60.0% |
Showing 1–48 of 48 weeks
Key facts
CIK
1716166
CUSIP
92859E207
13F (30d)
21 filings
21 filers
Visit website
Investor relations